Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market
Holding ADIL?
Track your performance easily

Adial Pharmaceuticals (ADIL) Financial Statements

465 Followers

Adial Pharmaceuticals Financial Overview

Adial Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.078; its P/E ratio is -0.19; Adial Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 450.00K--
Gross Profit--$ 450.00K--
EBIT$ -2.46M$ 931.57K$ -1.24M$ -1.35M$ -1.51M
EBITDA$ -2.46M$ 931.71K$ -1.24M$ -1.35M$ -1.53M
Net Income Common Stockholders$ -2.46M$ -6.48M$ -1.92M$ -1.38M$ 1.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.29M$ 5.03M$ 2.83M$ 315.88K$ 1.22M
Total Assets$ 4.95M$ 6.68M$ 4.74M$ 2.87M$ 3.78M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.29M$ -5.03M$ -2.83M$ -315.88K$ -1.22M
Total Liabilities$ 671.88K$ 562.73K$ 653.08K$ 528.18K$ 461.75K
Stockholders Equity$ 4.28M$ 6.12M$ 4.08M$ 2.34M$ 3.32M
Cash Flow-
Free Cash Flow$ -2.15M$ -1.63M$ -872.55K$ -1.04M$ -1.11M
Operating Cash Flow$ -2.15M$ -1.63M$ -1.22M$ -1.39M$ -1.91M
Investing Cash Flow--$ 350.00K$ 350.00K$ 800.00K
Financing Cash Flow$ 411.09K$ 3.82M$ 3.38M$ 138.67K$ 58.00
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

Adial Pharmaceuticals Debt to Assets

Adial Pharmaceuticals Cash Flow

Adial Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis